Clinical Trial: A Long-Term Follow-Up Trial for Participants Enrolled in CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) Trials

U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07683897) titled 'A Long-Term Follow-Up Trial for Participants Enrolled in CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) Trials' on June 27.

Brief Summary: This is an open label, multi-center, long-term safety and efficacy follow-up trial for participants who have been treated with Senza5 CART5.

Study Start Date: July, 2026

Study Type: OBSERVATIONAL

Condition: Participants Treated With Senza5

Intervention: BIOLOGICAL: Senza5 CART5

Senza5 CART5

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Vittoria Biotherapeutics

Disclaimer: Curated by HT Syndication....